Enterprise Value
$3.78 B
-$115.80 M-2.97%
Wed, 26 Feb 2025 00:59:13 GMT
Summary
- As of February 26, 2025, CRSP enterprise value is $3.78 billion, with a fall of -$115.80 million (-2.97%) during the most recent trading day.
- Over the past year, CRSP enterprise value has dropped by -$2.77 billion (-42.35%).
- CRSP enterprise value is now -73.81% below its all-time high of $14.42 billion.
Performance
CRSP Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Enterprise Value Formula
Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents
CRSP Enterprise Value Trends
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | -3.0% | -2.9% | -2.9% |
| 1 m1 month | +3.6% | +3.5% | +3.5% |
| 3 m3 months | -11.5% | -9.7% | -10.2% |
| 6 m6 months | -3.5% | -7.5% | -8.2% |
| ytdytd | +14.5% | +14.2% | +14.1% |
| 1 y1 year | -42.4% | -42.5% | -46.2% |
| 5 y5 years | +76.1% | +26.9% | -10.0% |
CRSP Enterprise Value Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -15.6% | $3.33 B | +13.5% | |
| 3 m | 3-month | $4.71 B | -19.8% | $3.22 B | +17.3% |
| 6 m | 6-month | $4.74 B | -20.3% | $3.22 B | +17.3% |
| 1 y | 1-year | $7.36 B | -48.7% | $3.22 B | +17.3% |
| 3 y | 3-year | $7.36 B | -48.7% | $2.79 B | +35.2% |
| 5 y | 5-year | $14 B | -73.8% | $1.16 B | +225.7% |
| alltime | all time | $14 B | -73.8% | $256 M | +1375.9% |
CRISPR Therapeutics AG Enterprise Value History
| Date | Value |
|---|---|
| 2025 | $3.78 B(+14.5%) |
| 2024 | $3.30 B(-32.3%) |
| 2023 | $4.88 B(+47.2%) |
| 2022 | $3.31 B(-35.5%) |
| 2021 | $5.14 B(-49.7%) |
| Date | Value |
|---|---|
| 2020 | $10.21 B(+263.2%) |
| 2019 | $2.81 B(+174.3%) |
| 2018 | $1.02 B(+43.7%) |
| 2017 | $713.35 M(+45.8%) |
| 2016 | $489.20 M |
FAQ
- What is CRISPR Therapeutics AG enterprise value?
- What is the all time high enterprise value for CRISPR Therapeutics AG?
- What is CRSP enterprise value year-to-date change?
- What is CRISPR Therapeutics AG enterprise value year-on-year change?
What is CRISPR Therapeutics AG enterprise value?
The current enterprise value of CRSP is $3.78 B
What is the all time high enterprise value for CRISPR Therapeutics AG?
CRISPR Therapeutics AG all-time high enterprise value is $14.42 B
What is CRSP enterprise value year-to-date change?
CRISPR Therapeutics AG enterprise value has changed by +$478.18 M (+14.50%) since the beginning of the year
What is CRISPR Therapeutics AG enterprise value year-on-year change?
Over the past year, CRSP enterprise value has changed by -$2.77 B (-42.35%)